NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
58 trialsNCT06896370 2026-02-25
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
Recruiting
NCT06192719 2026-02-18
EULAT
Centre Paul Strauss
Recruiting
NCT07400354 2026-02-10
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
Recruiting
NCT07177742 2026-02-06
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Shanghai Tongji Hospital, Tongji University School of Medicine
Recruiting
NCT07391007 2026-02-05
Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
Fudan University
Not yet recruiting
NCT06958328 2026-02-02
LAP100
NRG Oncology
Phase 3 Recruiting
NCT03533582 2025-12-22
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Children's Oncology Group
Phase 3 Active not recruiting
NCT07250100 2025-11-26
MICROPAC
Herlev Hospital
Recruiting
NCT04120935 2025-08-24
ALFAOMEGA
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT05101382 2025-08-24
ALFAOMEGA-R
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT03602092 2025-05-22
Observational Registry Data on GIST Patients
National Health Research Institutes, Taiwan
Recruiting
NCT04068103 2025-05-07
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Phase 2/3 Active not recruiting
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06933966 2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2 Not yet recruiting
NCT06875648 2025-03-18
Intestinal Flora Differences Between Colorectal Cancer Patients and Healthy Individuals
Hansung University
Completed
NCT06750159 2024-12-27
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
Peking Union Medical College Hospital
Not yet recruiting
NCT06706466 2024-11-26
Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
Fujian Medical University
Completed
NCT06637059 2024-10-15
Artificially Intelligent Model for Accurate Detection of HCC
Zhejiang University
Completed
NCT02135419 2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3 Completed
NCT06515964 2024-07-23
China Early Esophageal Cancer Cohort
Changhai Hospital
Recruiting
NCT06272214 2024-07-16
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT06493448 2024-07-10
Prospective Observational Cohort Study
Chinese PLA General Hospital
Not yet recruiting
NCT02355379 2024-07-08
ADAGE
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT06313567 2024-07-08
Metronomic Capecitabine in Stage III Gastric Cancer
Fudan University
Phase 3 Recruiting
NCT02109146 2024-05-29
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
Zhejiang University
Phase 3 Completed
NCT06379412 2024-04-26
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
Zhujiang Hospital
Recruiting
NCT05292443 2024-02-23
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
Withdrawn
NCT04893408 2023-11-30
Pancreatic Surgery in Elderly Patients
Rigshospitalet, Denmark
Completed
NCT06090825 2023-10-19
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
Peking Union Medical College Hospital
Unknown
NCT05620537 2023-02-13
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients
Jinling Hospital, China
Completed
NCT05661786 2022-12-22
PILOT
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
NCT05604716 2022-11-03
Cross-sectional Follow-up on Digestive and Social Functions of SPN
Peking Union Medical College Hospital
Recruiting
NCT01845805 2022-10-04
Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT05493956 2022-09-09
RACE-GB
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase NA Unknown
NCT05468138 2022-08-26
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
Phase 2 Unknown
NCT02503111 2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA Terminated
NCT05138302 2021-11-30
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients
RenJi Hospital
Unknown
NCT02073500 2021-07-28
PSM
Oslo University Hospital
Recruiting
NCT02113384 2021-07-28
LARC-EX
Oslo University Hospital
Active not recruiting
NCT04333927 2020-06-23
ACCORD
Sun Yat-sen University
Phase 2 Unknown
NCT04439812 2020-06-19
Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer
Hospital Universitario Ramon y Cajal
Completed
NCT02052921 2020-05-11
Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy
Instituto do Cancer do Estado de São Paulo
Phase NA Terminated
NCT03199989 2020-03-06
EPAC1
Peking University Cancer Hospital & Institute
Phase 3 Unknown
NCT01845753 2020-01-23
Molecular Screening for Lynch Syndrome in Denmark
Vejle Hospital
Completed
NCT03314649 2019-05-08
Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer
Fudan University
Completed
NCT03701373 2018-10-10
Maintenance Treatment With S-1 in Gastric Cancer Patients
Sun Yat-sen University
Phase 2 Unknown
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT03303833 2017-10-06
GEOLynch
Wageningen University
Recruiting
NCT00759109 2017-04-07
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
Merck Sharp & Dohme LLC
Phase 3 Completed